TCL Archive In Brief: Wieand Named Director, Biostatistical Center For NSABP; LeMaistre Honored By AMA June 30, 1995
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
